Edition:
United States

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

9.05USD
15 Dec 2017
Change (% chg)

$0.90 (+11.04%)
Prev Close
$8.15
Open
$8.15
Day's High
$9.50
Day's Low
$8.15
Volume
1,940,063
Avg. Vol
129,916
52-wk High
$9.50
52-wk Low
$4.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.350
Jun '17 0.00 -0.374
Mar '17 0.00 -0.332
FY 2016 Dec '16 0.00 -0.252
Sep '16 0.00 -1.154
Jun '16 0.00 -0.226
Mar '16 0.00 -0.142
FY 2015 Dec '15 0.00 -0.177
Sep '15 0.00 -0.162
Jun '15 0.00 -0.141
Mar '15 0.00 -0.141
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Year Ending Dec-17 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 7 -0.33 -0.30 -0.39 -0.23
Quarter Ending Mar-18 5 -0.34 -0.31 -0.39 -0.27
Year Ending Dec-17 7 -1.37 -1.23 -1.45 -0.98
Year Ending Dec-18 7 -1.40 -1.23 -1.58 -1.12
LT Growth Rate (%) 1 -19.00 -19.00 -19.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta 4.54 0.82 0.91
Price to Sales (TTM) -- 122.78 5.95
Price to Book (MRQ) 3.94 23.45 5.68
Price to Tangible Book (MRQ) 3.97 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 83.15 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -- 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 69.69 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 22.98 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate 117.78 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 20.09 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -- -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -- -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -- -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,314,532 851,801,741
Net Income/Employee (TTM) -1,605,843 -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.00 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.97 -9.39 11.31
Return on Assets - 5 Yr. Avg. -46.95 0.28 12.28
Return on Investment (TTM) -47.54 -11.76 14.43
Return on Investment - 5 Yr. Avg. -52.23 3.42 16.07
Return on Equity (TTM) -47.54 -36.72 16.01
Return on Equity - 5 Yr. Avg. -77.17 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -197.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Iovance Biotherapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.17%
# of Holders: 140
Total Shares Held: 60,406,873
3 Mo. Net Change: 7,777,645
# New Positions: 21
# Closed Positions: 17
# Increased Positions: 70
# Reduced Positions: 43
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.